
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">33253244</article-id><article-id pub-id-type="pmc">7703957</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0243124</article-id><article-id pub-id-type="publisher-id">PONE-D-20-30258</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Covid 19</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>China</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Medical Risk Factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Blood Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Lymphocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Lymphocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Lymphocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Lymphocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Blood Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Metaanalysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Metaanalysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Respiratory Disorders</subject><subj-group><subject>Dyspnea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Disorders</subject><subj-group><subject>Dyspnea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Metrics</subject><subj-group><subject>Death Rates</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis</article-title><alt-title alt-title-type="running-head">Risk factors for COVID-19 patients</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9112-4137</contrib-id><name><surname>Yang</surname><given-names>Lan</given-names></name><role content-type="https://casrai.org/credit/">Data curation</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Software</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jin</surname><given-names>Jing</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Software</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Wenxin</given-names></name><role content-type="https://casrai.org/credit/">Funding acquisition</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Software</role><role content-type="https://casrai.org/credit/">Visualization</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Gan</surname><given-names>Yuncui</given-names></name><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Software</role><role content-type="https://casrai.org/credit/">Validation</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Bojiang</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref><xref ref-type="corresp" rid="cor001">*</xref><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Weimin</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Funding acquisition</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref><xref ref-type="corresp" rid="cor001">*</xref><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Department of Respiratory and Critical Care Medicine, West China Medical School/West China Hospital, Sichuan University, Chengdu, Sichuan, China</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Serra</surname><given-names>Raffaele</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University Magna Graecia of Catanzaro, ITALY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; These authors also contributed equally to this work.</p></fn><corresp id="cor001">* E-mail: <email>weimi003@yahoo.com</email> (WL); <email>Cjhcbj@gmail.com</email> (BC)</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>11</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>15</volume><issue>11</issue><elocation-id>e0243124</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Yang et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Yang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0243124.pdf"/><abstract><sec id="sec001"><title>Background</title><p>Early and accurate prognosis prediction of the patients was urgently warranted due to the widespread popularity of COVID-19. We performed a meta-analysis aimed at comprehensively summarizing the clinical characteristics and laboratory abnormalities correlated with increased risk of mortality in COVID-19 patients.</p></sec><sec id="sec002"><title>Methods</title><p>PubMed, Scopus, Web of Science, and Embase were systematically searched for studies considering the relationship between COVID-19 and mortality up to 4 June 2020. Data were extracted including clinical characteristics and laboratory examination.</p></sec><sec id="sec003"><title>Results</title><p>Thirty-one studies involving 9407 COVID-19 patients were included. Dyspnea (OR = 4.52, 95%CI [3.15, 6.48], P &#x0003c; 0.001), chest tightness (OR = 2.50, 95%CI [1.78, 3.52], P&#x0003c;0.001), hemoptysis (OR = 2.00, 95%CI [1.02, 3.93], P = 0.045), expectoration (OR = 1.52, 95%CI [1.17, 1.97], P = 0.002) and fatigue (OR = 1.27, 95%CI [1.09, 1.48], P = 0.003) were significantly related to increased risk of mortality in COVID-19 patients. Furthermore, increased pretreatment absolute leukocyte count (OR = 11.11, 95%CI [6.85,18.03], P&#x0003c;0.001) and decreased pretreatment absolute lymphocyte count (OR = 9.83, 95%CI [6.72, 14.38], P&#x0003c;0.001) were also associated with increased mortality of COVID-19. We also compared the mean value of them between survivors and non-survivors, and found that non-survivors showed significantly raise in pretreatment absolute leukocyte count (WMD: 3.27&#x000d7;10<sup>9</sup>/L, 95%CI [2.34, 4.21], P&#x0003c;0.001) and reduction in pretreatment absolute lymphocyte count (WMD = -0.39&#x000d7;10<sup>9</sup>/L, 95%CI [-0.46, -0.33], P&#x0003c;0.001) compared with survivors. The results of pretreatment lactate dehydrogenase (LDH), procalcitonin (PCT), D-Dimer and ferritin showed the similar trend with pretreatment absolute leukocyte count.</p></sec><sec id="sec004"><title>Conclusions</title><p>Among the common symptoms of COVID-19 infections, fatigue, expectoration, hemoptysis, dyspnea and chest tightness were independent predictors of death. As for laboratory examinations, significantly increased pretreatment absolute leukocytosis count, LDH, PCT, D-Dimer and ferritin, and decreased pretreatment absolute lymphocyte count were found in non-survivors, which also have an unbeneficial impact on mortality among COVID-19 patients. Motoring these indicators during the hospitalization plays a very important role in predicting the prognosis of patients.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>91859203</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Weimin</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81871890</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Weimin</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100013076</institution-id><institution>National Major Science and Technology Projects of China</institution></institution-wrap></funding-source><award-id>2020-YF08-00080-GX</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Wenxin</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by National Nature Science Foundation of China [grant numbers 91859203 and 81871890] and Major Science and Technology Innovation Project of Chengdu City [grant number 2020-YF08-00080-GX].</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="11"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its <xref ref-type="sec" rid="sec019">Supporting Information</xref> files.</meta-value></custom-meta><custom-meta id="outbreaks"><meta-name>Outbreaks</meta-name><meta-value>COVID-19</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its <xref ref-type="sec" rid="sec019">Supporting Information</xref> files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Since December 2019, the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia has caused more than 8 million infections, with 440,290 deaths worldwide until June 17th, 2020 [<xref rid="pone.0243124.ref001" ref-type="bibr">1</xref>]. Increasing evidence is investigating the clinical features and laboratory abnormalities in patients with COVID-19 infection. Considering the widespread of COVID-19, early and accurate prognosis prediction is urgently warranted. However, the specific symptoms and laboratory biomarkers which may help predict the poor prognosis of COVID-19 patients were unclear. Therefore, we aimed to perform a systematic meta-analysis to summarize the clinical characteristics and laboratory test before treatment among COVID-19 patients and identify the possible risk factors for mortality.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Materials and methods</title><sec id="sec007"><title>Search strategy</title><p>We conducted a systematic search in PubMed, Scopus, Web of Science and Embase to identify studies in patients with COVID-19 infection up to 4 June 2020. The following keywords were used: &#x0201c;2019 novel coronavirus disease&#x0201d;, &#x0201c;severe acute respiratory syndrome coronavirus 2&#x0201d;, &#x0201c;COVID-19&#x0201d;, &#x0201c;2019-nCoV&#x0201d;, &#x0201c;SARS-CoV-2&#x0201d; and &#x0201c;clinical&#x0201d;, &#x0201c;laboratory&#x0201d;, &#x0201c;risk factor&#x0201d;, and &#x0201c;mortality&#x0201d;, &#x0201c;mortal&#x0201d;, &#x0201c;fatality&#x0201d;, &#x0201c;fatal&#x0201d;, &#x0201c;lethality&#x0201d; or &#x0201c;death&#x0201d;. No restrictions on publication status were imposed. Only studies published in English and Chinese were retrieved for this meta-analysis. In addition, reference lists of relevant records were manually screened for further potentially eligible articles.</p></sec><sec id="sec008"><title>Inclusion criteria and exclusion criteria</title><p>Two researchers reviewed all articles independently based on titles and abstracts. The inclusion criteria were as follows: 1) all patients were confirmed with COVID-19; 2) studies reported the clinical characteristics, hematological and serological abnormalities both in survivors and non-survivors.</p><p>The exclusion criteria were as follows: 1) reviews, letters, case reports, conference abstracts and duplicated publications; 2) insufficient data were provided for extrapolating the mean&#x000b1;SD for hematologic parameters.</p></sec><sec id="sec009"><title>Data extraction and assessment of risk of bias</title><p>Studies that met the inclusion and exclusion criteria underwent full-text rescreening. Data extraction was performed by two investigators independently. The following data were collected: the name of first author, publication year, region of studies, number of the patients with COVID-19, clinical characteristics together with of the laboratory examination in each group. Continuous data were extracted as mean &#x000b1; standard deviation (SD). While data were expressed as median, range and/or interquartile range (IQR), mean and SD were extrapolated according to Wan et al. [<xref rid="pone.0243124.ref002" ref-type="bibr">2</xref>]. Any disagreements were resolved via discussion and consensus. The risk of bias of each included study was assessed by utilizing the MINORS score [<xref rid="pone.0243124.ref003" ref-type="bibr">3</xref>].</p></sec><sec id="sec010"><title>Statistical analysis</title><p>ORs together with the weighted mean difference (WMD) and the 95% confidence interval (CI) were merged and we assessed heterogeneity by using Cochran&#x02019;s Q statistic test and the I<sup>2</sup> statistic. When p-values for heterogeneity were no greater than 0.05 or I<sup>2</sup> value exceeded 50%, random-model was applied. Otherwise, the fixed-effects model was adopted. We explored the publication bias by the Egger&#x02019;s regression test and the funnel plot. All statistical analyses were conducted by Review Manager (version 5.3), and R (version 3.6.1). Two-tailed P values &#x02264;0.05 were considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec011"><title>Results</title><sec id="sec012"><title>Literature search and assessment of risk of bias</title><p>A total of 3093 potentially relevant publications were yielded according to our search strategy from PubMed, Scopus, Web of Science and Embase up to 4 June 2020. One additional relevant study was identified from the reference list of included articles. We discarded 1177 articles as duplicates. Two researchers reviewed 1917 articles based on titles and abstracts. After 1839 irrelevant records were excluded, we screened the full text versions of the remaining 78 articles. The following studies were eliminated: reviews, meta-analyses or case reports and studies lacking sufficient data for further analysis. Ultimately, thirty-one qualified articles [<xref rid="pone.0243124.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0243124.ref034" ref-type="bibr">34</xref>] were included in this meta-analysis. The detailed process of the literature search was presented in <bold><xref ref-type="fig" rid="pone.0243124.g001">Fig 1</xref></bold>. All included studies were non-randomized. The MINORS scores varied between 18 and 21, suggesting a low risk of bias overall (<bold><xref rid="pone.0243124.t001" ref-type="table">Table 1</xref> and <xref ref-type="supplementary-material" rid="pone.0243124.s004">S1 Table</xref></bold>).</p><fig id="pone.0243124.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0243124.g001</object-id><label>Fig 1</label><caption><title>Flow chart of the literature search.</title></caption><graphic xlink:href="pone.0243124.g001"/></fig><table-wrap id="pone.0243124.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0243124.t001</object-id><label>Table 1</label><caption><title>Characteristics of all included studies.</title></caption><alternatives><graphic id="pone.0243124.t001g" xlink:href="pone.0243124.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Author</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">Country</th><th align="center" rowspan="1" colspan="1">City</th><th align="center" rowspan="1" colspan="1">MINORS score</th><th align="center" colspan="2" rowspan="1">Total<break/>S NS</th><th align="center" colspan="2" rowspan="1">Age<break/>S NS</th><th align="center" colspan="2" rowspan="1">Male (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">Hypertension (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">Diabetes (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">Malignancy (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">CCD (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">CB (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">CRD (%)<break/>S NS</th><th align="center" colspan="2" rowspan="1">COPD (%)<break/>S NS</th></tr></thead><tbody><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Cao JL</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">53 (47, 66)</td><td align="center" rowspan="1" colspan="1">72 (63, 81)</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">77</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Chen RC</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Guangzhou</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">445</td><td align="center" rowspan="1" colspan="1">103</td><td align="center" rowspan="1" colspan="1">53.5 (13.9)</td><td align="center" rowspan="1" colspan="1">66.9 (12.1)</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Chen RC (2)</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Guangzhou</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1540</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">48 (1&#x02013;94) <xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">69 (51&#x02013;86) <xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Chen T</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">161</td><td align="center" rowspan="1" colspan="1">113</td><td align="center" rowspan="1" colspan="1">51 (37, 66)</td><td align="center" rowspan="1" colspan="1">68 (62, 77)</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Deng Y</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">116</td><td align="center" rowspan="1" colspan="1">109</td><td align="center" rowspan="1" colspan="1">40 (33, 57)</td><td align="center" rowspan="1" colspan="1">69 (62, 74)</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Du RH</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">158</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">56 (13.5)</td><td align="center" rowspan="1" colspan="1">70.2 (7.7)</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1">Fan H <xref ref-type="table-fn" rid="t001fn003">*</xref></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">46.2 (12)</td><td align="center" rowspan="1" colspan="1">65.5 (9.7)</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Goicoechea M</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">Spain</td><td align="center" rowspan="1" colspan="1">Madrid</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">69 (14)</td><td align="center" rowspan="1" colspan="1">75 (6)</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Giacomelli A</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">Italy</td><td align="center" rowspan="1" colspan="1">Milan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">185</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Huang J</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Yichang</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">283</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">52.5 (16.6)</td><td align="center" rowspan="1" colspan="1">69.2 (9.7)</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">19</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Javanian M</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">Iran</td><td align="center" rowspan="1" colspan="1">Babol</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">81</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">57.7 (13.6)</td><td align="center" rowspan="1" colspan="1">69.3 (11.1)</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">26</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Li LL</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">43.7 (13.1)</td><td align="center" rowspan="1" colspan="1">69 (10.5)</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">8</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Nowak B</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">Poland</td><td align="center" rowspan="1" colspan="1">Warsaw</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">59.3 (20.1)</td><td align="center" rowspan="1" colspan="1">75.3 (11.9)</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ruan QR</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">50 (44, 81)</td><td align="center" rowspan="1" colspan="1">67 (15, 81)</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">72</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Shi Q</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">259</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Shi SB <xref ref-type="table-fn" rid="t001fn003">*</xref></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Shanghai</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">609</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">61 (49, 70)</td><td align="center" rowspan="1" colspan="1">74 (66, 81)</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Sun H</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">121</td><td align="center" rowspan="1" colspan="1">67 (64, 72)</td><td align="center" rowspan="1" colspan="1">72 (66, 78)</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Tang N</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">162</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">52.4 (15.6)</td><td align="center" rowspan="1" colspan="1">64 (20.7)</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Wang DW</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">88</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">44.5 (35, 58.8)</td><td align="center" rowspan="1" colspan="1">73 (64, 81)</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wang K</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">470</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">58 (46&#x02013;67) <xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">67 (61.8&#x02013;78) <xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1">Wang L (1) <sup>1</sup></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">274</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">68 (64, 74)</td><td align="center" rowspan="1" colspan="1">76 (70, 83)</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wang L (2)</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">169</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">61 (49, 67)</td><td align="center" rowspan="1" colspan="1">74 (65, 84)</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1">Wang Y <xref ref-type="table-fn" rid="t001fn003">*</xref></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Nanjing</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">211</td><td align="center" rowspan="1" colspan="1">133</td><td align="center" rowspan="1" colspan="1">57 (47&#x02013;69)</td><td align="center" rowspan="1" colspan="1">70 (62&#x02013;77)</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu CM <xref ref-type="table-fn" rid="t001fn003">*</xref></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">50 (40.3, 56.8)</td><td align="center" rowspan="1" colspan="1">68.5 (59.3, 75)</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Xu PP</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">MC</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">659</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">45 (14.6)</td><td align="center" rowspan="1" colspan="1">64.7 (13.4)</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">73</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Xu B</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">117</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">56 (43, 66)</td><td align="center" rowspan="1" colspan="1">73 (68, 77.3)</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1">Yang XB <xref ref-type="table-fn" rid="t001fn003">*</xref></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">51.9 (12.9)</td><td align="center" rowspan="1" colspan="1">64.6 (11.2)</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Yang KY</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">MCr</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">165</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">62 (57, 69)</td><td align="center" rowspan="1" colspan="1">63 (53, 75)</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">73</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Yan XS</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">964</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">62 (50, 70)</td><td align="center" rowspan="1" colspan="1">68 (58, 79)</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Zhang J <xref ref-type="table-fn" rid="t001fn003">*</xref></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">68 (38, 87)</td><td align="center" rowspan="1" colspan="1">77 (66, 91)</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Zhou F</bold></td><td align="center" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">Wuhan</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">137</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">52 (45, 58)</td><td align="center" rowspan="1" colspan="1">69 (63, 76)</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">7</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Abbreviation: COVID-19, coronavirus disease 2019; S: survivors; NS: non-survivors; CCD: Chronic cardiac disease; CB: Cerebrovascular disease; CRD: Chronic renal disease; COPD: Chronic obstructive pulmonary disease; MINORS: Methodological Index for Non-Randomized Studies; NA, Not available; MC: Multi-center.</p></fn><fn id="t001fn002"><p>a: Reported as median (range). Other studies were reported as median (IQR) or mean (SD).</p></fn><fn id="t001fn003"><p>*: All patients with ARDS or severe/critically ill patients.</p></fn><fn id="t001fn004"><p><sup>1</sup>: All patients were over 60 years old.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec013"><title>Characteristics of included studies</title><p>As shown in <bold><xref rid="pone.0243124.t001" ref-type="table">Table 1</xref></bold>, the included studies were carried out in China (n = 27), Spain (n = 1), Italy (n = 1), Iran (n = 1) and Poland (n = 1). In total, 9407 confirmed COVID-19 patients were included, of which 7856 were survivors and 1551 were non-survivors. The mean or median age of survivors varied from 40 to 69 years, and that of the non-survivors ranged between 63 to 75.3 years. The proportions of male patients in survivors and non-survivors were 52% and 65%, respectively. For comorbidities, similar to the findings of Ielapi N et al. [<xref rid="pone.0243124.ref035" ref-type="bibr">35</xref>], a history of hypertension was more common among non-survivors (52%) than among survivors (29%). Similar to hypertension, non-survivors were more likely to report having diabetes, malignancy, chronic obstructive pulmonary disease, chronic cardiac disease, cerebrovascular disease and chronic renal disease (<bold><xref rid="pone.0243124.t001" ref-type="table">Table 1</xref></bold>). Clinical characteristics included fever, cough, dyspnea, fatigue, diarrhea, myalgia, expectoration, headache, emesis, pharyngalgia, anorexia, abdominal pain, dizziness, hemoptysis, nausea, chest pain, chest tightness and shiver. As for laboratory test, we focused on leukocytes, lymphocytes, procalcitonin (PCT), D-Dimer, lactate dehydrogenase (LDH) and ferritin. Of these studies, nineteen studies provided the clinical characteristics and the laboratory findings of COVID-19 patients [<xref rid="pone.0243124.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0243124.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0243124.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0243124.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0243124.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0243124.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0243124.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0243124.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0243124.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0243124.ref026" ref-type="bibr">26</xref>&#x02013;<xref rid="pone.0243124.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0243124.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pone.0243124.ref034" ref-type="bibr">34</xref>], seven studies only targeted the clinical characteristics [<xref rid="pone.0243124.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0243124.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0243124.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0243124.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0243124.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0243124.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0243124.ref029" ref-type="bibr">29</xref>], and another five studies only focused on the laboratory findings [<xref rid="pone.0243124.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0243124.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0243124.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0243124.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0243124.ref030" ref-type="bibr">30</xref>].</p></sec><sec id="sec014"><title>Meta-analysis results of clinical characteristics</title><p>Twenty-six studies involving 7274 COVID-19 patients (5926 survivors and 1348 non-survivors) provided data regarding clinical characteristics (<bold><xref ref-type="supplementary-material" rid="pone.0243124.s005">S2 Table</xref></bold>). The association between various clinical characteristics and the risk of mortality in COVID-19 patients were shown in <bold><xref ref-type="fig" rid="pone.0243124.g002">Fig 2</xref></bold>. Compared with survivors, non-survivors were more likely to present with dyspnea (66% vs. 34%), chest tightness (46% vs. 30%), hemoptysis (4% vs. 3%), expectoration (42% vs. 32%) and fatigue (50% vs. 44%) (<bold><xref ref-type="supplementary-material" rid="pone.0243124.s005">S2 Table</xref></bold>). In addition, dyspnea, chest tightness, hemoptysis, expectoration and fatigue were observed as significant poor risk factors of mortality (dyspnea: OR = 4.52, 95%CI [3.15, 6.48], P&#x0003c;0.001; chest tightness: OR = 2.50, 95%CI [1.78, 3.52], P&#x0003c;0.001; hemoptysis: OR = 2.00, 95%CI [1.02, 3.93], P = 0.045; expectoration: OR = 1.52, 95%CI [1.17, 1.97], P = 0.002; and fatigue: OR = 1.27, 95%CI [1.09, 1.48], P = 0.003). The heterogeneity test results of dyspnea, chest tightness, hemoptysis, expectoration and fatigue evaluated by I<sup>2</sup> were 79%, 2%, 0%, 51% and 10%, respectively. However, no significant relationships were found between mortality and fever, cough, diarrhea, headache, abdominal pain, dizziness, nausea, chest pain and so on (<bold><xref ref-type="fig" rid="pone.0243124.g002">Fig 2</xref></bold>).</p><fig id="pone.0243124.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0243124.g002</object-id><label>Fig 2</label><caption><title>Meta-analysis results of the relationship between clinical manifestation and the increasing risk of mortality in COVID-19 patients.</title><p>Abbreviation: OR, odds ratio; CI, confidence interval.</p></caption><graphic xlink:href="pone.0243124.g002"/></fig></sec><sec id="sec015"><title>Meta-analysis results of laboratory findings</title><p>A total of twenty-four studies consisting of 5900 cases (4639 survivors and 1261 non-survivors) reported laboratory findings of COVID-19 patients (<bold><xref ref-type="supplementary-material" rid="pone.0243124.s006">S3 Table</xref></bold>). We compared the pretreatment absolute leukocytes count, absolute leukocytes count, LDH, D-Dimer, PCT and ferritin between survivors and non-survivors. Compared with survivors, significant increases were found in non-survivors in pretreatment absolute leukocytes count (WMD = 3.27&#x000d7;10<sup>9</sup>/L, 95% CI [2.34, 4.21], P&#x0003c;0.001) (<bold><xref rid="pone.0243124.t002" ref-type="table">Table 2</xref></bold>, <bold><xref ref-type="supplementary-material" rid="pone.0243124.s001">S1 Fig</xref></bold>) and we further observed significant negative correlation between the risk of mortality and decreased pretreatment absolute leukocytes count (OR = 0.32, 95%CI [0.22, 0.46], P&#x0003c;0.001; I<sup>2</sup> = 44%, P = 0.11) (<bold><xref ref-type="fig" rid="pone.0243124.g003">Fig 3</xref></bold>). The mean value of pretreatment absolute lymphocytes count was significantly decreased in non-survivors with a WMD of -0.39&#x000d7;10<sup>9</sup>/L, 95% CI [-0.46, -0.33]; P&#x0003c;0.001) compared with survivors (<bold><xref rid="pone.0243124.t002" ref-type="table">Table 2</xref></bold>, <bold><xref ref-type="supplementary-material" rid="pone.0243124.s001">S1 Fig</xref></bold>) and the reduction of pretreatment absolute lymphocytes count was also significantly related to the increased risk of mortality (OR = 9.83, 95%CI [6.72, 14.38], P&#x0003c;0.001). No pronounced heterogeneity was observed by the heterogeneity test (I<sup>2</sup> = 0%, P = 0.515) (<bold><xref ref-type="fig" rid="pone.0243124.g003">Fig 3</xref></bold>). What&#x02019;s more, LDH, D-Dimer, PCT and ferritin were also found to be elevated in non-survivors (<bold><xref rid="pone.0243124.t002" ref-type="table">Table 2</xref></bold>, <bold><xref ref-type="supplementary-material" rid="pone.0243124.s001">S1 Fig</xref></bold>) and the increased indicators mentioned above were also associated with increased risk of mortality (<bold><xref ref-type="fig" rid="pone.0243124.g003">Fig 3</xref></bold>).</p><fig id="pone.0243124.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0243124.g003</object-id><label>Fig 3</label><caption><title>Meta-analysis results of the relationship between laboratory abnormalities and the increasing risk of mortality in COVID-19 patients.</title><p>Abbreviation: OR, odds ratio; CI, confidence interval.</p></caption><graphic xlink:href="pone.0243124.g003"/></fig><table-wrap id="pone.0243124.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0243124.t002</object-id><label>Table 2</label><caption><title>Meta-analysis results of comparing laboratory abnormalities between survivor and non-survivor COVID-19 patients.</title></caption><alternatives><graphic id="pone.0243124.t002g" xlink:href="pone.0243124.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Laboratory findings</th><th align="center" rowspan="1" colspan="1">No. of the studies</th><th align="center" rowspan="1" colspan="1">No. of the patients</th><th align="center" rowspan="1" colspan="1">WMD</th><th align="center" rowspan="1" colspan="1">P</th><th align="center" colspan="2" rowspan="1">Test of heterogeneity<break/>I<sup>2</sup> (%) <italic>P</italic></th></tr></thead><tbody><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1">Leukocytes (&#x000d7;10<sup>9</sup>/L)</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">5408</td><td align="center" rowspan="1" colspan="1">3.27 (2.34, 4.21)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytes (&#x000d7;10<sup>9</sup>/L)</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">4825</td><td align="center" rowspan="1" colspan="1">-0.39 (-0.46, -0.33)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>Lactate dehydrogenase (LDH) (U/L)</bold></td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">3336</td><td align="center" rowspan="1" colspan="1">211.60 (148.63, 274.57)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Procalcitonin (ng/mL)</bold></td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">3330</td><td align="center" rowspan="1" colspan="1">0.31 (0.20, 0.42)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">88</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr style="background-color:#CCCCCC"><td align="left" rowspan="1" colspan="1"><bold>D-Dimer (&#x003bc;g/mL)</bold></td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">3108</td><td align="center" rowspan="1" colspan="1">4.97 (3.55, 6.39)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ferritin (ng/mL)</bold></td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1500</td><td align="center" rowspan="1" colspan="1">770.05 (530.34, 1009.76)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Abbreviation: WMD, weighted mean difference; LDH, lactate dehydrogenase.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec016"><title>Publication bias</title><p>The funnel plots and Egger&#x02019;s tests showed that there was no evidence of publication bias either in any clinical characteristic analysis or in any laboratory test analysis <bold>(<xref ref-type="supplementary-material" rid="pone.0243124.s002">S2</xref> and <xref ref-type="supplementary-material" rid="pone.0243124.s003">S3</xref> Figs)</bold>.</p></sec></sec><sec sec-type="conclusions" id="sec017"><title>Discussion</title><p>In this article, we summarized the incidence of some common symptoms of COVID-19 infections and found that dyspnea, chest tightness, hemoptysis, expectoration and fatigue were significantly associated with poor prognosis in COVID-19 patients. For laboratory tests, our study indicated significant increased pretreatment absolute leukocytes count and decreased pretreatment absolute lymphocytes count were observed in non-survivors and they were also associated with the increased risk of mortality in COVID-19 patients.</p><p>As an emerging infectious disease, the rapid global rise of COVID-19 pneumonia infections and deaths has attracted significant attention. To foresee the prognosis of COVID-19 infected individuals, it is essential to ascertain the risk factors for death fast and reliably. A large number of clinical studies have explored the clinical characteristics and laboratory examinations of severe and critical COVID-19 patients. Zheng et al. [<xref rid="pone.0243124.ref036" ref-type="bibr">36</xref>] reported that the fever, shortness of breath or dyspnea indicated the disease deterioration. Our results were consistent with the findings of Shi et al. that the presence of dyspnea was risk factors for death, rather than fever [<xref rid="pone.0243124.ref037" ref-type="bibr">37</xref>]. Another recent retrospective study of 179 patients with confirmed COVID-19 found that fatigue and expectoration were more frequently observed in non-survivors than survivors, which were associated with increased risk of mortality [<xref rid="pone.0243124.ref009" ref-type="bibr">9</xref>]. Hemoptysis was an uncommon symptom in COVID-19 patients [<xref rid="pone.0243124.ref038" ref-type="bibr">38</xref>]. In several studies, the incidence of hemoptysis was higher in survivors [<xref rid="pone.0243124.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0243124.ref014" ref-type="bibr">14</xref>], while many others reported that hemoptysis occurred more often in non-survivors [<xref rid="pone.0243124.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0243124.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0243124.ref017" ref-type="bibr">17</xref>], consistent with our observations. More researches on the role of hemoptysis in predicting the prognosis of COVID-19 patients was required.</p><p>For laboratory tests, in addition to pretreatment absolute leukocytes and lymphocytes count, increased LDH, PCT, and ferritin were also observed in non-survivors. Further analyses showed them were all associated with the mortality of patients.</p><p>Concerning lymphocyte, some studies found no significant correlation between lymphocyte counts and the severity of the disease [<xref rid="pone.0243124.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0243124.ref040" ref-type="bibr">40</xref>], whereas other research concluded that lymphopenia was a good predictor of disease progression [<xref rid="pone.0243124.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0243124.ref042" ref-type="bibr">42</xref>]. The present study is the first meta-analysis, which identified the correlation between lymphopenia and mortality in COVID-19 patients. Regardless of the baseline disease severity, lymphocyte was significantly lower on admission and maintained a lower level during hospitalization in non-survivors, while it increased after treatment in survivors [<xref rid="pone.0243124.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0243124.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0243124.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0243124.ref044" ref-type="bibr">44</xref>]. The lymphopenia may result from destruction of lymphocytes (particularly T lymphocytes) and suppression of the proliferation of lymphocytes caused by virus invasion, and recovered lymphocyte could be a predictor of gradual recovery [<xref rid="pone.0243124.ref045" ref-type="bibr">45</xref>].</p><p>The present study had some limitations that should be acknowledged. First, all included studies were retrospective. Secondly, subgroup analyses were not performed due to the limited data we can draw from the enrolled studies. Additionally, due to the limitations of language, we included the studies written in English and Chinese only.</p></sec><sec sec-type="conclusions" id="sec018"><title>Conclusions</title><p>To sum up, we found that dyspnea, chest tightness, hemoptysis, expectoration and fatigue were predictors of increased risk of mortality. Besides, significantly increased pretreatment absolute leukocyte count, PCT, D-Dimer, LDH and ferritin, and decreased pretreatment absolute lymphocyte count were identified in non-survivors, which were all related to increased risk of mortality. Motoring these indicators during the hospitalization of patients plays a very important role in predicting the prognosis of patients. Collectively, our results are helpful in clinical practice, which should be verified by additional large-sample or multi-center studies.</p></sec><sec sec-type="supplementary-material" id="sec019"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0243124.s001"><label>S1 Fig</label><caption><p>Forest plot of the laboratory abnormalities (A) leukocytes, (B) lymphocytes, (C) lactate dehydrogenase (LDH), (D) procalcitonin, (E) D-Dimer, (F) ferritin levels in survivors versus non-survivors.</p><p>(TIF)</p></caption><media xlink:href="pone.0243124.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s002"><label>S2 Fig</label><caption><p>The publication bias of the clinical characteristics (A. dyspnea; B. chest tightness; C. hemoptysis; D. expectoration; E. fatigue; F. anorexia; G. dizziness; H. chest pain; I. fever; J. nausea; K. cough; L. emesis; M. headache; N. myalgia; O. diarrhea; P. pharyngalgia; Q. abdominal pain; R. shiver) between survivors and non-survivors.</p><p>(TIF)</p></caption><media xlink:href="pone.0243124.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s003"><label>S3 Fig</label><caption><p>The publication bias of the laboratory abnormalities (A) increased leukocytes, (B) decreased leukocytes, (C) decreased lymphocytes, (D) increased lactate dehydrogenase (LDH), (E) increased procalcitonin (PCT), (F) increased D-Dimer, (G) increased ferritin between survivors and non-survivors.</p><p>(TIF)</p></caption><media xlink:href="pone.0243124.s003.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s004"><label>S1 Table</label><caption><title>The results of the quality assessment for each individual study.</title><p>(XLSX)</p></caption><media xlink:href="pone.0243124.s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s005"><label>S2 Table</label><caption><title>Clinical characteristics of survivor and non-survivor COVID-19 patients.</title><p>Abbreviation: CI, confidence interval; NA, not available.</p><p>(XLSX)</p></caption><media xlink:href="pone.0243124.s005.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s006"><label>S3 Table</label><caption><title>Laboratory abnormalities of survivor and non-survivor COVID-19 patients.</title><p>Abbreviation: CI, confidence interval; SD, standard deviation.</p><p>(XLSX)</p></caption><media xlink:href="pone.0243124.s006.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s007"><label>S1 File</label><caption><title>Prisma-2009-checklist.</title><p>(DOC)</p></caption><media xlink:href="pone.0243124.s007.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0243124.s008"><label>S2 File</label><caption><title>Search strategy for meta-analysis of risk factors for predicting mortality of COVID-19 patients (PubMed via NLM).</title><p>(DOCX)</p></caption><media xlink:href="pone.0243124.s008.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>COVID-19</term><def><p>coronavirus disease 2019</p></def></def-item><def-item><term>SARS-CoV-2</term><def><p>severe acute respiratory syndrome coronavirus 2</p></def></def-item><def-item><term>IQR</term><def><p>interquartile range</p></def></def-item><def-item><term>SARS</term><def><p>severe acute respiratory syndrome</p></def></def-item><def-item><term>CI</term><def><p>confidence interval</p></def></def-item><def-item><term>LDH</term><def><p>lactate dehydrogenase</p></def></def-item><def-item><term>PCT</term><def><p>procalcitonin</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pone.0243124.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>YR</given-names></name>, <name><surname>Cao</surname><given-names>QD</given-names></name>, <name><surname>Hong</surname><given-names>ZS</given-names></name>, <name><surname>Tan</surname><given-names>YY</given-names></name>, <name><surname>Chen</surname><given-names>SD</given-names></name>, <name><surname>Jin</surname><given-names>HJ</given-names></name>, <etal>et al</etal>
<article-title>The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak&#x02014;an update on the status.</article-title>
<source>Military Medical Research.</source>
<year>2020</year>;<volume>7</volume>(<issue>1</issue>):<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1186/s40779-020-00240-0</pub-id>
<pub-id pub-id-type="pmid">32169119</pub-id></mixed-citation></ref><ref id="pone.0243124.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Wan</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Tong</surname><given-names>T</given-names></name>. <article-title>Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.</article-title>
<source>BMC Med Res Methodol.</source>
<year>2014</year>;<volume>14</volume>:<fpage>135</fpage>&#x02013;. <pub-id pub-id-type="doi">10.1186/1471-2288-14-135</pub-id>
<pub-id pub-id-type="pmid">25524443</pub-id></mixed-citation></ref><ref id="pone.0243124.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Slim</surname><given-names>K</given-names></name>, <name><surname>Nini</surname><given-names>E</given-names></name>, <name><surname>Forestier</surname><given-names>D</given-names></name>, <name><surname>Kwiatkowski</surname><given-names>F</given-names></name>, <name><surname>Panis</surname><given-names>Y</given-names></name>, <name><surname>Chipponi</surname><given-names>J</given-names></name>. <article-title>Methodological index for non-randomized studies (MINORS): development and validation of a new instrument.</article-title>
<source>ANZ Journal of Surgery</source>. <year>2003</year>;<volume>73</volume>(<issue>9</issue>):<fpage>712</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1046/j.1445-2197.2003.02748.x</pub-id>
<pub-id pub-id-type="pmid">12956787</pub-id></mixed-citation></ref><ref id="pone.0243124.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Cao</surname><given-names>J</given-names></name>, <name><surname>Tu</surname><given-names>WJ</given-names></name>, <name><surname>Cheng</surname><given-names>W</given-names></name>, <name><surname>Yu</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>YK</given-names></name>, <name><surname>Hu</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China.</article-title>
<source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>. <year>2020</year>.</mixed-citation></ref><ref id="pone.0243124.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>R</given-names></name>, <name><surname>Liang</surname><given-names>W</given-names></name>, <name><surname>Jiang</surname><given-names>M</given-names></name>, <name><surname>Guan</surname><given-names>W</given-names></name>, <name><surname>Zhan</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.</article-title>
<source>Chest</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.chest.2020.04.010</pub-id>
<pub-id pub-id-type="pmid">32304772</pub-id></mixed-citation></ref><ref id="pone.0243124.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>R</given-names></name>, <name><surname>Sang</surname><given-names>L</given-names></name>, <name><surname>Jiang</surname><given-names>M</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Jia</surname><given-names>N</given-names></name>, <name><surname>Fu</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China</article-title>. <source>The Journal of allergy and clinical immunology</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jaci.2020.05.003</pub-id>
<pub-id pub-id-type="pmid">32407836</pub-id></mixed-citation></ref><ref id="pone.0243124.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>T</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Yan</surname><given-names>W</given-names></name>, <name><surname>Yang</surname><given-names>D</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.</article-title>
<source>BMJ (Clinical research ed).</source>
<year>2020</year>;<volume>368</volume>:<fpage>m1091</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.m1091</pub-id>
<pub-id pub-id-type="pmid">32217556</pub-id></mixed-citation></ref><ref id="pone.0243124.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Liu</surname><given-names>K</given-names></name>, <name><surname>Fang</surname><given-names>YY</given-names></name>, <name><surname>Shang</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study.</article-title>
<source>Chinese medical journal</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1097/CM9.0000000000000824</pub-id>
<pub-id pub-id-type="pmid">32209890</pub-id></mixed-citation></ref><ref id="pone.0243124.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Du</surname><given-names>RH</given-names></name>, <name><surname>Liang</surname><given-names>LR</given-names></name>, <name><surname>Yang</surname><given-names>CQ</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Cao</surname><given-names>TZ</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study</article-title>. <source>The European respiratory journal</source>. <year>2020</year>;<volume>55</volume>(<issue>5</issue>).</mixed-citation></ref><ref id="pone.0243124.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Huang</surname><given-names>B</given-names></name>, <name><surname>Zhu</surname><given-names>M</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.</article-title>
<source>International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases.</source>
<year>2020</year>;<volume>96</volume>:<fpage>294</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.05.024</pub-id>
<pub-id pub-id-type="pmid">32437935</pub-id></mixed-citation></ref><ref id="pone.0243124.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Giacomelli</surname><given-names>A</given-names></name>, <name><surname>Ridolfo</surname><given-names>AL</given-names></name>, <name><surname>Milazzo</surname><given-names>L</given-names></name>, <name><surname>Oreni</surname><given-names>L</given-names></name>, <name><surname>Bernacchia</surname><given-names>D</given-names></name>, <name><surname>Siano</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study</article-title>. <source>Pharmacological research</source>. <year>2020</year>:<fpage>104931</fpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104931</pub-id>
<pub-id pub-id-type="pmid">32446978</pub-id></mixed-citation></ref><ref id="pone.0243124.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Goicoechea</surname><given-names>M</given-names></name>, <name><surname>S&#x000e1;nchez C&#x000e1;mara</surname><given-names>LA</given-names></name>, <name><surname>Mac&#x000ed;as</surname><given-names>N</given-names></name>, <name><surname>Mu&#x000f1;oz de Morales</surname><given-names>A</given-names></name>, <name><surname>Gonz&#x000e1;lez Rojas</surname><given-names>&#x000c1;</given-names></name>, <name><surname>Bascu&#x000f1;ana</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain</article-title>. <source>Kidney international</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.kint.2020.04.031</pub-id>
<pub-id pub-id-type="pmid">32437770</pub-id></mixed-citation></ref><ref id="pone.0243124.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Cheng</surname><given-names>A</given-names></name>, <name><surname>Kumar</surname><given-names>R</given-names></name>, <name><surname>Fang</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>, <name><surname>Zhu</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity</article-title>. <source>Journal of medical virology</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.26003</pub-id>
<pub-id pub-id-type="pmid">32406952</pub-id></mixed-citation></ref><ref id="pone.0243124.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Javanian</surname><given-names>M</given-names></name>, <name><surname>Bayani</surname><given-names>M</given-names></name>, <name><surname>Shokri</surname><given-names>M</given-names></name>, <name><surname>Sadeghi-Haddad-Zavareh</surname><given-names>M</given-names></name>, <name><surname>Babazadeh</surname><given-names>A</given-names></name>, <name><surname>Yeganeh</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study</article-title>. <source>Romanian journal of internal medicine = Revue roumaine de medecine interne</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.2478/rjim-2020-0013</pub-id>
<pub-id pub-id-type="pmid">32396143</pub-id></mixed-citation></ref><ref id="pone.0243124.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Gui</surname><given-names>S</given-names></name>, <name><surname>Pan</surname><given-names>F</given-names></name>, <name><surname>Ye</surname><given-names>T</given-names></name>, <name><surname>Liang</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China.</article-title>
<source>Theranostics.</source>
<year>2020</year>;<volume>10</volume>(<issue>14</issue>):<fpage>6113</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.7150/thno.46569</pub-id>
<pub-id pub-id-type="pmid">32483442</pub-id></mixed-citation></ref><ref id="pone.0243124.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Nowak</surname><given-names>B</given-names></name>, <name><surname>Szyma&#x00144;ski</surname><given-names>P</given-names></name>, <name><surname>Pa&#x00144;kowski</surname><given-names>I</given-names></name>, <name><surname>Szarowska</surname><given-names>A</given-names></name>, <name><surname>&#x0017b;yci&#x00144;ska</surname><given-names>K</given-names></name>, <name><surname>Rogowski</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.</article-title>
<source>Polish archives of internal medicine</source>. <year>2020</year>;<volume>130</volume>(<issue>5</issue>):<fpage>407</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.20452/pamw.15361</pub-id>
<pub-id pub-id-type="pmid">32420710</pub-id></mixed-citation></ref><ref id="pone.0243124.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Ruan</surname><given-names>Q</given-names></name>, <name><surname>Yang</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Jiang</surname><given-names>L</given-names></name>, <name><surname>Song</surname><given-names>J</given-names></name>. <article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.</article-title>
<source>Intensive care medicine.</source>
<year>2020</year>;<volume>46</volume>(<issue>5</issue>):<fpage>846</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-020-05991-x</pub-id>
<pub-id pub-id-type="pmid">32125452</pub-id></mixed-citation></ref><ref id="pone.0243124.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Jiang</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Hu</surname><given-names>N</given-names></name>, <name><surname>Bimu</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.</article-title>
<source>Diabetes care</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.2337/dc20-0598</pub-id>
<pub-id pub-id-type="pmid">32409504</pub-id></mixed-citation></ref><ref id="pone.0243124.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>S</given-names></name>, <name><surname>Qin</surname><given-names>M</given-names></name>, <name><surname>Cai</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Shen</surname><given-names>B</given-names></name>, <name><surname>Yang</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019.</article-title>
<source>European heart journal</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehaa408</pub-id>
<pub-id pub-id-type="pmid">32391877</pub-id></mixed-citation></ref><ref id="pone.0243124.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>H</given-names></name>, <name><surname>Ning</surname><given-names>R</given-names></name>, <name><surname>Tao</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>C</given-names></name>, <name><surname>Deng</surname><given-names>X</given-names></name>, <name><surname>Zhao</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study</article-title>. <source>Journal of the American Geriatrics Society</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1111/jgs.16533</pub-id>
<pub-id pub-id-type="pmid">32383809</pub-id></mixed-citation></ref><ref id="pone.0243124.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>N</given-names></name>, <name><surname>Li</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Sun</surname><given-names>Z</given-names></name>. <article-title>Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.</article-title>
<source>Journal of thrombosis and haemostasis: JTH.</source>
<year>2020</year>;<volume>18</volume>(<issue>4</issue>):<fpage>844</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/jth.14768</pub-id>
<pub-id pub-id-type="pmid">32073213</pub-id></mixed-citation></ref><ref id="pone.0243124.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>D</given-names></name>, <name><surname>Yin</surname><given-names>Y</given-names></name>, <name><surname>Hu</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China.</article-title>
<source>Critical care (London, England).</source>
<year>2020</year>;<volume>24</volume>(<issue>1</issue>):<fpage>188</fpage>
<pub-id pub-id-type="doi">10.1186/s13054-020-02895-6</pub-id>
<pub-id pub-id-type="pmid">32354360</pub-id></mixed-citation></ref><ref id="pone.0243124.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Tao</surname><given-names>Y</given-names></name>, <name><surname>Xie</surname><given-names>M</given-names></name>. <article-title>15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study.</article-title>
<source>Intensive care medicine.</source>
<volume>2020</volume>:<fpage>1</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-020-06047-w</pub-id>
<pub-id pub-id-type="pmid">32328724</pub-id></mixed-citation></ref><ref id="pone.0243124.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Yu</surname><given-names>X</given-names></name>, <name><surname>Hu</surname><given-names>D</given-names></name>, <name><surname>Bao</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.</article-title>
<source>The Journal of infection</source>. <year>2020</year>;<volume>80</volume>(<issue>6</issue>):<fpage>639</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.019</pub-id>
<pub-id pub-id-type="pmid">32240670</pub-id></mixed-citation></ref><ref id="pone.0243124.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>He</surname><given-names>WB</given-names></name>, <name><surname>Yu</surname><given-names>XM</given-names></name>, <name><surname>Liu</surname><given-names>HF</given-names></name>, <name><surname>Zhou</surname><given-names>WJ</given-names></name>, <name><surname>Jiang</surname><given-names>H</given-names></name>. <article-title>Prognostic value of myocardial injury in patients with COVID-19.</article-title>
<source>[Zhonghua yan ke za zhi] Chinese journal of ophthalmology.</source>
<year>2020</year>;<volume>56</volume>(<issue>0</issue>):<fpage>E009</fpage>
<pub-id pub-id-type="doi">10.3760/cma.j.cn112148-20200313-00202</pub-id>
<pub-id pub-id-type="pmid">32283877</pub-id></mixed-citation></ref><ref id="pone.0243124.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>T</given-names></name>, <name><surname>Su</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19</article-title>. <source>American journal of respiratory and critical care medicine</source>. <year>2020</year>;<volume>201</volume>(<issue>11</issue>):<fpage>1430</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.202003-0736LE</pub-id>
<pub-id pub-id-type="pmid">32267160</pub-id></mixed-citation></ref><ref id="pone.0243124.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>C</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Cai</surname><given-names>Y</given-names></name>, <name><surname>Xia</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.</article-title>
<source>JAMA internal medicine</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1001/jamainternmed.2020.0994</pub-id>
<pub-id pub-id-type="pmid">32167524</pub-id></mixed-citation></ref><ref id="pone.0243124.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Fan</surname><given-names>CY</given-names></name>, <name><surname>Wang</surname><given-names>AL</given-names></name>, <name><surname>Zou</surname><given-names>YL</given-names></name>, <name><surname>Yu</surname><given-names>YH</given-names></name>, <name><surname>He</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.</article-title>
<source>The Journal of infection.</source>
<year>2020</year>.</mixed-citation></ref><ref id="pone.0243124.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>PP</given-names></name>, <name><surname>Tian</surname><given-names>RH</given-names></name>, <name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Zu</surname><given-names>ZY</given-names></name>, <name><surname>Fan</surname><given-names>B</given-names></name>, <name><surname>Wang</surname><given-names>XM</given-names></name>, <etal>et al</etal>
<article-title>Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.</article-title>
<source>Theranostics.</source>
<year>2020</year>;<volume>10</volume>(<issue>14</issue>):<fpage>6372</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.7150/thno.46833</pub-id>
<pub-id pub-id-type="pmid">32483458</pub-id></mixed-citation></ref><ref id="pone.0243124.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Yan</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>F</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Yan</surname><given-names>J</given-names></name>, <name><surname>Zhu</surname><given-names>F</given-names></name>, <name><surname>Tang</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-sectional Study.</article-title>
<source>Journal of medical virology</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.26061</pub-id>
<pub-id pub-id-type="pmid">32458459</pub-id></mixed-citation></ref><ref id="pone.0243124.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>K</given-names></name>, <name><surname>Sheng</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>C</given-names></name>, <name><surname>Jin</surname><given-names>Y</given-names></name>, <name><surname>Xiong</surname><given-names>N</given-names></name>, <name><surname>Jiang</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study</article-title>. <source>The Lancet Oncology</source>. <year>2020</year>.</mixed-citation></ref><ref id="pone.0243124.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Yu</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Shu</surname><given-names>H</given-names></name>, <name><surname>Xia</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</article-title>. <source>The Lancet Respiratory medicine</source>. <year>2020</year>;<volume>8</volume>(<issue>5</issue>):<fpage>475</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(20)30079-5</pub-id>
<pub-id pub-id-type="pmid">32105632</pub-id></mixed-citation></ref><ref id="pone.0243124.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>P</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Yuan</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study.</article-title>
<source>Zeitschrift fur Gesundheitswissenschaften = Journal of public health</source>. <year>2020</year>:<fpage>1</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="pone.0243124.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>F</given-names></name>, <name><surname>Yu</surname><given-names>T</given-names></name>, <name><surname>Du</surname><given-names>R</given-names></name>, <name><surname>Fan</surname><given-names>G</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title>. <source>Lancet (London, England).</source>
<year>2020</year>;<volume>395</volume>(<issue>10229</issue>):<fpage>1054</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30566-3</pub-id>
<pub-id pub-id-type="pmid">32171076</pub-id></mixed-citation></ref><ref id="pone.0243124.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Ielapi</surname><given-names>N</given-names></name>, <name><surname>Licastro</surname><given-names>N</given-names></name>, <name><surname>Provenzano</surname><given-names>M</given-names></name>, <name><surname>Andreucci</surname><given-names>M</given-names></name>, <name><surname>Franciscis</surname><given-names>Sd</given-names></name>, <name><surname>Serra</surname><given-names>R</given-names></name>. <article-title>Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.</article-title>
<source>Biomark Med.</source>
<year>2020</year>;<volume>14</volume>(<issue>9</issue>):<fpage>713</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2217/bmm-2020-0201</pub-id>
<pub-id pub-id-type="pmid">32426991</pub-id></mixed-citation></ref><ref id="pone.0243124.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>Z</given-names></name>, <name><surname>Peng</surname><given-names>F</given-names></name>, <name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Peng</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Risk factors of critical &#x00026; mortal COVID-19 cases: A systematic literature review and meta-analysis</article-title>. <source>The Journal of infection</source>. <year>2020</year>:<fpage>S0163</fpage>&#x02013;<lpage>4453</lpage>(20)30234-6.</mixed-citation></ref><ref id="pone.0243124.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Duan</surname><given-names>G</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>. <article-title>Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19</article-title>. <source>The Journal of infection</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.013</pub-id>
<pub-id pub-id-type="pmid">32417316</pub-id></mixed-citation></ref><ref id="pone.0243124.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Guan</surname><given-names>WJ</given-names></name>, <name><surname>Ni</surname><given-names>ZY</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Liang</surname><given-names>WH</given-names></name>, <name><surname>Ou</surname><given-names>CQ</given-names></name>, <name><surname>He</surname><given-names>JX</given-names></name>, <etal>et al</etal>
<article-title>Clinical Characteristics of Coronavirus Disease 2019 in China.</article-title>
<source>The New England journal of medicine</source>. <year>2020</year>;<volume>382</volume>(<issue>18</issue>):<fpage>1708</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id>
<pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="pone.0243124.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Yuan</surname><given-names>T</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Ao</surname><given-names>Y</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.</article-title>
<source>The Journal of infection</source>. <year>2020</year>;<volume>80</volume>(<issue>6</issue>):<fpage>656</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.041</pub-id>
<pub-id pub-id-type="pmid">32283155</pub-id></mixed-citation></ref><ref id="pone.0243124.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>HG</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>K</given-names></name>, <name><surname>Shang</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia.</article-title>
<source>Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases</source>. <year>2020</year>;<volume>43</volume>(<issue>0</issue>):<fpage>E005</fpage>
<pub-id pub-id-type="doi">10.3760/cma.j.issn.1001-0939.2020.0005</pub-id>
<pub-id pub-id-type="pmid">32026671</pub-id></mixed-citation></ref><ref id="pone.0243124.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Q</given-names></name>, <name><surname>Meng</surname><given-names>M</given-names></name>, <name><surname>Kumar</surname><given-names>R</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Deng</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.</article-title>
<source>International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases</source>. <year>2020</year>;<volume>96</volume>:<fpage>131</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.04.086</pub-id>
<pub-id pub-id-type="pmid">32376308</pub-id></mixed-citation></ref><ref id="pone.0243124.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>I</given-names></name>, <name><surname>Pranata</surname><given-names>R</given-names></name>. <article-title>Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.</article-title>
<source>Journal of intensive care</source>. <year>2020</year>;<volume>8</volume>:<fpage>36</fpage>&#x02013;. <pub-id pub-id-type="doi">10.1186/s40560-020-00453-4</pub-id>
<pub-id pub-id-type="pmid">32483488</pub-id></mixed-citation></ref><ref id="pone.0243124.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>N</given-names></name>, <name><surname>Zhou</surname><given-names>M</given-names></name>, <name><surname>Dong</surname><given-names>X</given-names></name>, <name><surname>Qu</surname><given-names>J</given-names></name>, <name><surname>Gong</surname><given-names>F</given-names></name>, <name><surname>Han</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.</article-title>
<source>Lancet (London, England).</source>
<year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>507</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id>
<pub-id pub-id-type="pmid">32007143</pub-id></mixed-citation></ref><ref id="pone.0243124.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Guan</surname><given-names>WJ</given-names></name>, <name><surname>Liang</surname><given-names>WH</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Liang</surname><given-names>HR</given-names></name>, <name><surname>Chen</surname><given-names>ZS</given-names></name>, <name><surname>Li</surname><given-names>YM</given-names></name>, <etal>et al</etal>
<article-title>Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis</article-title>. <source>The European respiratory journal</source>. <year>2020</year>;<volume>55</volume>(<issue>5</issue>). <pub-id pub-id-type="doi">10.1183/13993003.00547-2020</pub-id>
<pub-id pub-id-type="pmid">32217650</pub-id></mixed-citation></ref><ref id="pone.0243124.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Gu</surname><given-names>J</given-names></name>, <name><surname>Gong</surname><given-names>E</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name>, <name><surname>Zheng</surname><given-names>J</given-names></name>, <name><surname>Gao</surname><given-names>Z</given-names></name>, <name><surname>Zhong</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Multiple organ infection and the pathogenesis of SARS</article-title>. <source>The Journal of experimental medicine</source>. <year>2005</year>;<volume>202</volume>(<issue>3</issue>):<fpage>415</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20050828</pub-id>
<pub-id pub-id-type="pmid">16043521</pub-id></mixed-citation></ref></ref-list></back><sub-article id="pone.0243124.r001" article-type="aggregated-review-documents"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0243124.r001</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Serra</surname><given-names>Raffaele</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2020 Raffaele Serra</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Raffaele Serra</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pone.0243124" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">27 Oct 2020</named-content>
</p><p>PONE-D-20-30258</p><p>Risk factors for predicting&#x000a0;mortality of COVID-19 patients : A systematic review and meta-analysis</p><p>PLOS ONE</p><p>Dear Dr. Li,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x02019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>The reviewers have commented on your above paper. They have suggested that this manuscript be revised according to the reviewers suggestions and resubmitted. &#x000a0;Provided you address the changes recommended, the manuscript will be accepted for publication</p><p>Please submit your revised manuscript by Nov 29 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:</p><p><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see:&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Prof. Raffaele Serra, M.D., Ph.D</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p><p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p><p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p><p>2. Please attach a Supplemental file of the results of the quality assessment for each individual study assessed, reporting the outcome for each individual criteria considered.</p><p>3. Please include the date(s) on which you accessed the databases or records to obtain the data used in your study.</p><p>4. Please provide a citation for the MINORS score.</p><p>5.Thank you for stating the following in the Funding Section of your manuscript:</p><p>[This work was supported by National Nature Science Foundation of China [grant</p><p>227 numbers 91859203 and 81871890] and Major Science and Technology Innovation</p><p>228 Project of Chengdu City [grant number 2020-YF08-00080-GX]]</p><p>We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.</p><p>Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:</p><p>&#x000a0;[The author(s) received no specific funding for this work.]</p><p>Please include your amended statements within your cover letter; we will change the online submission form on your behalf.</p><p>6. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. &#x000a0;</p><p>Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (<ext-link ext-link-type="uri" xlink:href="about:blank">http://learn.aje.com/plos/</ext-link>) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (<ext-link ext-link-type="uri" xlink:href="http://www.editage.com">www.editage.com</ext-link>) and enter referral code PLOSEDIT for a 15% discount off Editage services.&#x000a0; If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.</p><p>Upon resubmission, please provide the following:</p><p><list list-type="bullet"><list-item><p>The name of the colleague or the details of the professional service that edited your manuscript</p></list-item><list-item><p>A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)</p></list-item><list-item><p>A clean copy of the edited manuscript (uploaded as the new *manuscript* file)</p></list-item></list></p><p>Additional Editor Comments (if provided):</p><p>The reviewers have commented on your above paper. They have suggested that this manuscript be revised according to the reviewers suggestions and resubmitted.</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p><bold>Comments to the Author</bold></p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#x000a0;Yes</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#x000a0;Yes</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link ext-link-type="uri" xlink:href="http://www.plosone.org/static/policies.action#sharing">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x02014;e.g. participant privacy or use of data from a third party&#x02014;those must be specified.</p><p>Reviewer #1:&#x000a0;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#x000a0;Yes</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#x000a0;The authors aimed to perform a systematic meta-analysis to summarize the clinical characteristics and laboratory test before treatment among COVID-19 patients 65 and identify the possible risk factors for mortality. The article is timely and novel and it is overall well structured and written.</p><p>Nevertheless, I would improve the manuscript focusing also on cardiovascular disease that increases poor prognosis and related mortality. For this purpose read and cite the article by Ielapi N, et al. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med. 2020 Jun;14(9):713-716.</p><p>**********</p><p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p><p>Reviewer #1:&#x000a0;No</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#x000a0;<ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#x000a0;<email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p></body></sub-article><sub-article id="pone.0243124.r002" article-type="author-comment"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0243124.r002</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pone.0243124" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">6 Nov 2020</named-content>
</p><p>Dear Editor-in-Chief and reviewers:</p><p>Thank you for your letter and for the reviewers' comments concerning our manuscript entitled &#x0201c;Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis&#x0201d;. All suggestions were very helpful for us to revise and improve our paper. We carefully studied these comments and made corrections that we hope meet with approval. The revised portions are marked with &#x02018;Track changes&#x02019; in the manuscript.</p><p>Here are my responses to the Editor-in-Chief&#x02019; comments.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p><p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p><p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p><p>Response: We have now re-formatted our paper carefully to meet PLOS ONE&#x02019;s style requirements.</p><p>2. Please attach a Supplemental file of the results of the quality assessment for each individual study assessed, reporting the outcome for each individual criteria considered.</p><p>Response: The results of the quality assessment for each individual study were presented in S1 Table. We have added S1 table in the revised version of our manuscript. We change the original &#x0201c;eTable 1&#x0201d; to &#x0201c;S2 Table&#x0201d; and the original &#x0201c;eTable 2&#x0201d; to &#x0201c;S3 Table&#x0201d;. We are sorry for making some mistakes in calculating the MINORS scores. After re-calculating all scores of enrolled studies, the MINORS score of Chen T(2020) was changed from 18 to 21, the MINORS score of Goicoechea M (2020) was changed from 21 to 18, and the MINORS score of Zhou F (2020) was changed from 18 to 21.(Page 8-10, Table 1)</p><p>3. Please include the date(s) on which you accessed the databases or records to obtain the data used in your study.</p><p>Response: We conducted a systematic search in PubMed, Scopus, Web of Science and Embase to identify studies in patients with COVID-19 infection up to 4 June 2020. This was mentioned in &#x0201c;Materials and methods&#x0201d;-&#x0201c;Search strategy&#x0201d;. (Page 4, Line 64).</p><p>4. Please provide a citation for the MINORS score.</p><p>Response: The citation for the MINORS score was provided as reference [3]. (Page 5, Line 88)</p><p>Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ Journal of Surgery. 2003;73(9):712-6.</p><p>5.Thank you for stating the following in the Funding Section of your manuscript:</p><p>[This work was supported by National Nature Science Foundation of China [grant</p><p>227 numbers 91859203 and 81871890] and Major Science and Technology Innovation</p><p>228 Project of Chengdu City [grant number 2020-YF08-00080-GX]]</p><p>We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.</p><p>Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:</p><p> [The author(s) received no specific funding for this work.]</p><p>Please include your amended statements within your cover letter; we will change the online submission form on your behalf.</p><p>Response: We have removed any funding-related text from the manuscript and add the information of funding in cover letter.</p><p>6. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.</p><p>Response: The full manuscript has been reviewed and edited by a professional scientific English editor.</p><p>Here are my responses to the reviewers&#x02019; comments.</p><p>Reviewer #1: The authors aimed to perform a systematic meta-analysis to summarize the clinical characteristics and laboratory test before treatment among COVID-19 patients 65 and identify the possible risk factors for mortality. The article is timely and novel and it is overall well structured and written.</p><p>Nevertheless, I would improve the manuscript focusing also on cardiovascular disease that increases poor prognosis and related mortality. For this purpose read and cite the article by Ielapi N, et al. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med. 2020 Jun;14(9):713-716.</p><p>Response: Thank you for reviewing our manuscript and your advices were helpful. According to your suggestion about the impact of cardiovascular disease on COVID-19 infection and prognosis. We did analysis to detect the relationship between hypertension and chronic cardiac disease and mortality of COVID-19. The results showed that hypertension (OR= 2.94, 95%CI [2.39, 3.62], P&#x0003c;0.001) and chronic cardiac disease (OR= 3.89, 95%CI [2.65, 5.72], P&#x0003c;0.001), were also associated with increased mortality of COVID-19. The detail information was provided in the following table.</p><p>&#x03000; No. of the studies No. of the patients OR, 95%CI P-value Heterogeneity</p><p> I2 P-value</p><p>Hypertension 28 8939 2.94 [2.39, 3.62] &#x0003c;0.001 54.90% &#x0003c;0.001</p><p>CCD 17 3806 3.89 [2.65, 5.72] &#x0003c;0.001 53.40% 0.005</p><p>We appreciate the editor/reviewers' earnest work and hope that the corrections will make the revised manuscript acceptable for publication. Once again, thank you very much for your comments and suggestions, and we look forward to hearing from you.</p><supplementary-material content-type="local-data" id="pone.0243124.s009"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p></caption><media xlink:href="pone.0243124.s009.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article id="pone.0243124.r003" article-type="editor-report"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0243124.r003</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Serra</surname><given-names>Raffaele</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2020 Raffaele Serra</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Raffaele Serra</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pone.0243124" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">17 Nov 2020</named-content>
</p><p>Risk factors for predicting&#x000a0; mortality of COVID-19 patients : A systematic review and meta-analysis</p><p>PONE-D-20-30258R1</p><p>Dear Dr. Li,</p><p>We&#x02019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#x02019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x02019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link ext-link-type="uri" xlink:href="http://www.editorialmanager.com/pone/">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x02019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p><p>Kind regards,</p><p>Prof. Raffaele Serra, M.D., Ph.D</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p>amended manuscript is acceptable.</p><p>Reviewers' comments:</p></body></sub-article><sub-article id="pone.0243124.r004" article-type="editor-report"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0243124.r004</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Serra</surname><given-names>Raffaele</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2020 Raffaele Serra</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Raffaele Serra</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pone.0243124" related-article-type="reviewed-article"/></front-stub><body><p>
<named-content content-type="letter-date">19 Nov 2020</named-content>
</p><p>PONE-D-20-30258R1 </p><p>
Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis
</p><p>Dear Dr. Li:</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p><p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p><p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p><p>Thank you for submitting your work to PLOS ONE and supporting open access. </p><p>Kind regards, </p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Prof. Raffaele Serra </p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article>